Lead Sponsor

Mundipharma AB

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

•1. Males and females, age 18-65 years.
•2. Subjects diagnosed with asthma.
•3. Subjects with a baseline FEV1 of ≥70% of the predicted value.
•4. Outpatients at primary clinic.
•5. Subjects treated with a fixed dose combination for at least the last three months.
•6. Subjects who have withheld their asthma- and allergy medication according to individual instructions at the day of the challenge test.
•7. Subjects who are able to read and comprehend Swedish and are willing to sign an informed consent.

•1. Subjects with evidence of any other respiratory and/or obstructive disease including recent infection/exacerbation.
•2. Subjects treated with a oral corticosteroid within 4 weeks (28 days) prior to the day of the challenge test.
•3. Any history of hypersensitivity to mannitol challenge test.
•4. Any contraindications to use of the diagnostic study medication.
•5. Subjects who are unsuitable for other reason(s) in the opinion of the investigator.